Stay updated on Enzalutamide Benefit in Docetaxel Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Benefit in Docetaxel Clinical Trial page.

Latest updates to the Enzalutamide Benefit in Docetaxel Clinical Trial page
- Check7 days agoChange DetectedThe footer now shows Revision: v3.3.4, replacing Revision: v3.3.3, which is a minor version label update.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page footer now shows a new 'Revision: v3.3.3' label, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history shows a new revision entry (v3.3.2). An older revision (v3.2.0) appears to have been removed from the list.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page header banner about government funding lapse and NIH operating status was removed. This banner was ancillary to the study record and does not affect the trial data or history presented on the page.SummaryDifference0.3%

- Check85 days agoChange DetectedThe history list now includes additional version entries reflecting updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check107 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference9%

Stay in the know with updates to Enzalutamide Benefit in Docetaxel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Benefit in Docetaxel Clinical Trial page.